Curi Wealth Management, LLC Amgen Inc Transaction History

Curi Wealth Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $1,534 - $1,730	-6 Reduced 0.5%	1,186 $341,000
Q3 2023 Nov 06, 2023	SELL	$218.65 - $271.46 $60,784 - $75,465	-278 Reduced 18.91%	1,192 $320,000
Q2 2023 Jul 31, 2023	SELL	$214.27 - $253.37 $451,038 - $533,343	-2,105 Reduced 58.88%	1,470 $326,000
Q1 2023 May 03, 2023	SELL	$225.79 - $275.2 $903 - $1,100	-4 Reduced 0.11%	3,575 $864,000
Q4 2022 Feb 03, 2023	SELL	$229.03 - $291.01 $311,938 - $396,355	-1,362 Reduced 27.57%	3,579 $939,000
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $848,234 - $956,653	3,779 Added 325.22%	4,941 $1.11 Million
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $14,534 - $16,174	63 Added 5.73%	1,162 $283,000
Q1 2022 May 06, 2022	BUY	$219.27 - $242.57 $85,515 - $94,602	390 Added 55.01%	1,099 $265,000
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $141,005 - $161,368	709 New	709 $159,000
Q2 2021 Jul 23, 2021	SELL	$233.58 - $259.14 $192,937 - $214,049	-826 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$221.91 - $258.6 $7,101 - $8,275	32 Added 4.03%	826 $205,000
Q4 2020 Mar 19, 2021	BUY	$216.38 - $257.67 $171,805 - $204,589	794 New	794 $182,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Curi Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Curi Wealth Management, LLC with notifications on news.